RSS-Feed abonnieren
DOI: 10.1055/s-0032-1321785
Paracetamol (Acetaminophen) – a Popular and Widely Used Nonopioid Analgesic
Publikationsverlauf
received 31. Mai 2012
accepted 26. Juni 2012
Publikationsdatum:
01. August 2012 (online)
![](https://www.thieme-connect.de/media/amf/201208/lookinside/thumbnails/10.1055-s-0032-1321785-1.jpg)
Abstract
For several decades paracetamol has proven its clinical efficacy and safety in the treatment of various acute and chronic pain states. Whereas its pharmacokinetic properties (high oral bioavailability, good penetration into the brain, relative rapid hepatic elimination) are well known, its exact central mode of action remains to be elucidated. According to many international guidelines/recommendations paracetamol is a drug of first choice for relieving mild to moderate pain. It has been successfully combined with opioids for severe pain. Due to its cardiovascular, renal and gastrointestinal safety paracetamol offers several advantages vs. NSAIDs. It should be realized that the maximum daily dose is restricted to 4 g to avoid unnecessary hepatic complications. Keeping this limitation in mind paracetamol still represents a valuable first-line agent in the pharmacological management of pain.
-
References
- 1 Bertolini A, Ferrari A, Ottani A et al. Paracetamol: new vistas of an old drug. CNS Drug Rev 2006; 12: 250-275
- 2 Nikles CJ, Yelland M, Del MC et al. The role of paracetamol in chronic pain: an evidence-based approach. Am J Ther 2005; 12: 80-91
- 3 American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons . Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009; 57: 1331-1346
- 4 Guggenheimer J, Moore PA. The therapeutic applications of and risks associated with acetaminophen use: a review and update. J Am Dent Assoc 2011; 142: 38-44
- 5 Flood J. The role of acetaminophen in the treatment of osteoarthritis. Am J Manag Care 2010; 16 (Suppl Management) S48-S54
- 6 Reid MC, Shengelia R, Parker SJ. Pharmacologic management of osteoarthritis-related pain in older adults: a review shows that many drug therapies provide small-to-modest pain relief. Orthop Nurs 2012; 31: 109-114
- 7 Goldstein LH, Berlin M, Berkovitch M et al. Effectiveness of oral vs rectal acetaminophen: a meta-analysis. Arch Pediatr Adolesc Med 2008; 162: 1042-1046
- 8 Jahr JS, Lee VK. Intravenous acetaminophen. Anesthesiol Clin 2010; 28: 619-645
- 9 Jones VM. Acetaminophen injection: a review of clinical information. J Pain Palliat Care Pharmacother 2011; 25: 340-349
- 10 Purssell E. Systematic review of studies comparing combined treatment with paracetamol and ibuprofen, with either drug alone. Arch Dis Child 2011; 96: 1175-1179
- 11 de Vries F, Setakis E, van Staa TP. Concomitant use of ibuprofen and paracetamol and the risk of major clinical safety outcomes. Br J Clin Pharmacol 2010; 70: 429-438
- 12 Toms L, Derry S, Moore RA et al. Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. Cochrane Database Syst Rev 2009; CD001547-
- 13 Dhillon S. Tramadol/paracetamol fixed-dose combination: a review of its use in the management of moderate to severe pain. Clin Drug Investig 2010; 30: 711-738
- 14 Sawaddiruk P. Tramadol hydrochloride/acetaminophen combination for the relief of acute pain. Drugs Today (Barc) 2011; 47: 763-772
- 15 Forrest JA, Clements JA, Prescott LF. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet 1982; 7: 93-107
- 16 Toussaint K, Yang XC, Zielinski MA et al. What do we (not) know about how paracetamol (acetaminophen) works?. J Clin Pharm Ther 2010; 35: 617-638
- 17 van der Marel CD, Anderson BJ, van Lingen RA et al. Paracetamol and metabolite pharmacokinetics in infants. Eur J Clin Pharmacol 2003; 59: 243-251
- 18 Mohammed BS, Engelhardt T, Cameron GA et al. Population pharmacokinetics of single-dose intravenous paracetamol in children. Br J Anaesth 2012; 108: 823-829
- 19 Liukas A, Kuusniemi K, Aantaa R et al. Pharmacokinetics of intravenous paracetamol in elderly patients. Clin Pharmacokinet 2011; 50: 121-129
- 20 Shinoda S, Aoyama T, Aoyama Y et al. Pharmacokinetics/pharmacodynamics of acetaminophen analgesia in Japanese patients with chronic pain. Biol Pharm Bull 2007; 30: 157-161
- 21 Bannwarth B, Pehourcq F. Pharmacologic basis for using paracetamol: pharmacokinetic and pharmacodynamic issues. Drugs 2003; 63 Spec No 2 5-13
- 22 Zhao L, Pickering G. Paracetamol metabolism and related genetic differences. Drug Metab Rev 2011; 43: 41-52
- 23 Gelotte CK, Auiler JF, Lynch JM et al. Disposition of acetaminophen at 4, 6, and 8 g/day for 3 days in healthy young adults. Clin Pharmacol Ther 2007; 81: 840-848
- 24 McQuay HJ, Moore RA. Dose-response in direct comparisons of different doses of aspirin, ibuprofen and paracetamol (acetaminophen) in analgesic studies. Br J Clin Pharmacol 2007; 63: 271-278
- 25 Pickering G, Loriot MA, Libert F et al. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther 2006; 79: 371-378
- 26 Pickering G, Esteve V, Loriot MA et al. Acetaminophen reinforces descending inhibitory pain pathways. Clin Pharmacol Ther 2008; 84: 47-51
- 27 Hogestatt ED, Jonsson BA, Ermund A et al. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem 2005; 280: 31405-31412
- 28 Andersson DA, Gentry C, Alenmyr L et al. TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Delta(9)-tetrahydrocannabiorcol. Nat Commun 2011; 2: 551
- 29 Toms L, McQuay HJ, Derry S et al. Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Cochrane Database Syst Rev 2008; CD004602-
- 30 Courtney P, Doherty M. Key questions concerning paracetamol and NSAIDs for osteoarthritis. Ann Rheum Dis 2002; 61: 767-773
- 31 Oscier CD, Milner QJ. Peri-operative use of paracetamol. Anaesthesia 2009; 64: 65-72
- 32 Benson GD, Koff RS, Tolman KG. The therapeutic use of acetaminophen in patients with liver disease. Am J Ther 2005; 12: 133-141
- 33 Petersen KU. Paracetamol und die Leber. MMV Forschr Med 2011; 153: 137-142
- 34 Lavonas EJ, Reynolds KM, Dart RC. Therapeutic acetaminophen is not associated with liver injury in children: a systematic review. Pediatrics 2010; 126: e1430-e1444
- 35 Southey ER, Soares-Weiser K, Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin 2009; 25: 2207-2222
- 36 Rumack BH, Bateman DN. Acetaminophen and acetylcysteine dose and duration: past, present and future. Clin Toxicol (Phila) 2012; 50: 91-98
- 37 Scialli AR, Ang R, Breitmeyer J et al. Childhood asthma and use during pregnancy of acetaminophen. A critical review. Reprod Toxicol 2010; 30: 508-519
- 38 Schnabel E, Heinrich J. Respiratory tract infections and not paracetamol medication during infancy are associated with asthma development in childhood. J Allergy Clin Immunol 2010; 126: 1071-1073
- 39 Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004; 328: 434
- 40 Risser A, Donovan D, Heintzman J et al. NSAID prescribing precautions. Am Fam Physician 2009; 80: 1371-1378
- 41 Mattia A, Coluzzi F. What anesthesiologists should know about paracetamol (acetaminophen). Minerva Anestesiol 2009; 75: 644-653
- 42 Lavonas EJ, Fries JF, Furst DE et al. Comparative risks of non-prescription analgesics: a structured topic review and research priorities. Expert Opin Drug Saf 2012; 11: 33-44
- 43 McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med 2011; 8 e1001098
- 44 Lanas A, Garcia-Tell G, Armada B et al. Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis. BMC Med 2011; 9: 38
- 45 Harirforoosh S, Jamali F. Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf 2009; 8: 669-681
- 46 Bavry AA, Khaliq A, Gong Y et al. Harmful effects of NSAIDs among patients with hypertension and coronary artery disease. Am J Med 2011; 124: 614-620
- 47 Merrill GF, Goldberg E. Antioxidant properties of acetaminophen and cardioprotection. Basic Res Cardiol 2001; 96: 423-430
- 48 Leshnower BG, Sakamoto H, Zeeshan A et al. Role of acetaminophen in acute myocardial infarction. Am J Physiol Heart Circ Physiol 2006; 290: H2424-H2431
- 49 Langman MJ, Weil J, Wainwright P et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-1078
- 50 Henry D, Lim LL, Garcia Rodriguez LA et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996; 312: 1563-1566
- 51 Laine L, Smith R, Min K et al. Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2006; 24: 751-767
- 52 Lanas A. A review of the gastrointestinal safety data – a gastroenterologist’s perspective. Rheumatology (Oxford) 2010; 49 (Suppl. 02) ii3-ii10
- 53 Fine PG. Treatment guidelines for the pharmacological management of pain in older persons. Pain Med 2012; 13 (Suppl. 02) S57-S66
- 54 Sarzi-Puttini P, Vellucci R, Zuccaro SM et al. The appropriate treatment of chronic pain. Clin Drug Investig 2012; 32 (Suppl. 01) 21-33